Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer.

Goleij P, Khazeei Tabari MA, Larsen DS, Hadipour M, Rezaee A, Poudineh M, Daglia M, Li T, Khan H, Liu L

DOI: 10.1186/s12935-025-03935-3
Published: 2026 May 28
Container: Cancer cell international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12935-025-03935-3,
  title = {Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer.},
  author = {Goleij P and Khazeei Tabari MA and Larsen DS and Hadipour M and Rezaee A and Poudineh M and Daglia M and Li T and Khan H and Liu L},
  year = {2026},
  journal = {Cancer cell international},
  doi = {10.1186/s12935-025-03935-3},
  url = {https://doi.org/10.1186/s12935-025-03935-3}
}

RIS

TY  - JOUR
TI  - Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer.
AU  - Goleij P
AU  - Khazeei Tabari MA
AU  - Larsen DS
AU  - Hadipour M
AU  - Rezaee A
AU  - Poudineh M
AU  - Daglia M
AU  - Li T
AU  - Khan H
AU  - Liu L
PY  - 2026
JO  - Cancer cell international
DO  - 10.1186/s12935-025-03935-3
UR  - https://doi.org/10.1186/s12935-025-03935-3
ER  -

APA

P, G., MA, K. T., DS, L., M, H., A, R., M, P., M, D., T, L., H, K., & L, L. (2026). Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer.. Cancer cell international. https://doi.org/10.1186/s12935-025-03935-3

Source records

pubmed · retrieved 2026-09-25T18:33:44.071Z